Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01150669 · ClinicalTrials.gov registry record
Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 18
- Enrollment target
NCT01150669: Completed study, sponsored by Children's Oncology Group.
NCT01150669 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01150669 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This research study is studying lestaurtinib with or with chemotherapy in samples from young patients with leukemia. Studying the effects of lestaurtinib with or without chemotherapy in cell samples from patients with cancer in the laboratory may help doctors learn more about the effects of this treatment on cancer cells. It may also help doctors identify biomarkers related to cancer.
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-07 |
| Est. Completion | 2016-05 |
What the finished NCT01150669 record still lists
NCT01150669 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01150669 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01150669 about?
NCT01150669 is a clinical study titled "Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia". This research study is studying lestaurtinib with or with chemotherapy in samples from young patients with leukemia. Studying the effects of lestaurtinib with or without chemotherapy in cell samples from patients with cancer in the laboratory may help doctors learn more about the effects of this tre...
What is the current status of trial NCT01150669?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2010-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01150669?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01150669?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia